Cardiac output Increases by 30-50% during mammal Ian pregnancy. This Increase Is reflected by elevation In both heart rate and stroke volume. The primary mechanism of Increased stroke volume appears to be cardiac enlargement, rather than increased preload, afterload, or contractll lty. Animal studies have shown that enlargement of the heart occurs prior to an Increase In uterine blood flow during pregnancy and this type of enlargement can be mimicked by sex steroid adm In I strati on.
Systemic vascular resistance greatly decreases during pregnancy and with sex steroid administration. It has been postulated that systemic vascular resistance may be a signal for heart size changes.
This study attempted to chronlcal ly decrease systemic vascular resistance by administration of an arterial vasodllator (hydralazlne) over a three week period to guinea pigs. At the time of study hemodynamlcs were measured which Included, heart rate, arterial pressure, right atrial pressure and cardiac output. In vitro left ventricular pressure volume relationships were also evaluated, as was total plasma volume.
Systemic vascular resistance after 21 days was sl lghtly, though not statistically slgnlf lcantly, decreased (0.319 ± 0.071 vs. 0.360 ± 0.088 Wood Units, p = n.s.>. This reflected a slight drop In mean arterial pressure (62 ± 8.6 vs. 64 ± 5.1 mm Hg, p = n.s.), as wel I as a sl lght Increase In cardiac oJtput (241 ± 34 vs. 230 ± 29 ml/min, p = n.s.). There was no detectable change Jn left ventricular chanber size as assessed by left ventricular pressure volume relationships. 
REVIEW OF THE LITERATURE
During pregnancy cardiac output Increases by 30-50% In al I mammals studied to date, Including humans (1) (2) (3) (4) (5) (6) . The time course of this Increase has been a topic of Investigation In the past, but most authorities report peak values by the second trimester (1, 2) . The determinants of cardiac output, stroke volume and heart rate, both increase during pregnancy (1, 2) . However, mechanisms responsible for these changes have been Inadequately explained. Recent studies from our laboratory In the Pygmy goat suggest that the heart rate Increase may be both mediated autonomlcal ly as wel I as mediated through a change In Intrinsic sinus node automatlcity (4) . The Increase In stroke volume Is also not agreed upon. The potential mechanisms by which stroke volume could be Increased are preload, afterload, and contractil tty.
Many studies have shown a 40-50% Increase In blood volume during pregnancy (2, 7, 8, 9) . This would seem to suggest that Increased preload (sarcomere length at the end of diastole) may be Important to Increased cardiac output. However, Infusion of whole blood or dextran
In amounts sufficient to double left ventricular fll ling pressure have shown only smal I changes In left ventricular dimensions, stroke volume, and cardiac output (10, 11) . This evidence suggests that an Increase In preload from Increased blood volume contributes I lttle to Increased stroke.volume during pregnancy. Moreover, studies in women (12) and pregnant guinea pigs (13) have failed to show Increased filling pressures.
Left ventricular function has been assessed by noninvasive measurements of contractll lty such as systolic time Intervals and echocardlographlc ejection phase Indices. Results from systol le time Interval studies have not been consistent. In one study Rubier et al. reported that the Isometric contraction period was shorter during the third trimester of pregnancy than postpartum and concluded that left ventricular contractll lty was greater during pregnancy (14) . Burg et al. also measured systol le time Intervals and reported a prolonged pre-ejection period and a shortened left ventricular ejection time, suggesting Impaired left ventricular performance (15) . A recent serial echocardlographlc study has shown that left ventricular performance Is not changed during pregnancy (16) . In addition, data suggest that calculations by systolic time Intervals are Influenced by maternal position (15, 16) . However, since these methods are sensitive to changes In preload and afterload, conclusions about ventricular function during pregnancy need qual lficatlon (17) .
Changes In afterload are also difficult to evaluate. Afterload Is probably best approximated by wal I stress of the ventricle. The parameters of left ventricular wal I stress are left ventricular chamber size and wal I thickness (La Place), and systemic vascular resistance (18) . Other factors also Include rate of ventricular emptying and aortic Impedance (18) . During pregnancy the left ventricular chamber size to wal I thickness ratio Increases which would tend to Increase afterload. However, systemic vascular resistance and aortic Impedance are reduced as Is left ventricular ejection time (16) , factors al I tending to reduce afterload.
A fourth determinant of stroke volume, ventricular enlargement, was shown as early as 1825 to occur In pregnancy (19) . With a larger heart, none of the traditional determinants of stroke volume need play a role. Experiments of near term guinea pig pregnancy have shown that the left ventricle Is remodeled so that Its volume Is larger at any given fll ling pressure (13) . Enlargement of the heart would have the advantage of Increasing stroke volume without changing f 11 (13) . The increase Jn left ventricular chcmber s!ze was associated with an increase Jn the ratio of left ventricular chamber radius TO wal I thickness, a morphologic change previously described as being associated with pregnancy (16) . Table I compares the cardiac enlargement associated with pregnancy to other known conditions associated with cardiac enlargement. As can be seen, the cardiac enlargement associated with pregnancy appears to be a unique physlologlc adaptation. 
Hormones have long been known to be powerful mediators of control mechanisms. Estrogen and progesterone levels are elevated In pregnancy. The corpus tuteum and the placenta both contribute to this Increase. In 1955, Brehm suggested that cardiac output may be regulated by peripheral resistance and that maternal hormones were a fundamental cause of cardiac variation. Exogenous estrogen administration was studied by Parer and Ueland in ewes (24) . They showed that cardiac output and heart rate were elevated and mean arterial pressure and peripheral resistance decreased. These changes were similar to those seen In pregnant ewes (25) . Other studies of women taking oral contraceptives have also demonstrated Increased cardiac output, stroke volume, blood volume and blood pressure (25, 27) . In one study, progesterone and estrogen were administered separately (28) . Cardiovascular changes similar to those in pregnancy were seen only in those patients given estrogen. Studies in our laboratory on guinea pigs chronically receiving progesterone and/or estrogen conf lrm these observations. Estrogen treated animals had slgnlf lcant Increases In cardiac output, stroke volume, blood volume and left ventricular chamber size compared to controls, essentially mimicking the hemodynamlc changes seen In pregnancy. Several studies of hormone receptors have shown that the heart and major arteries have estrogen and androgen receptors, suggesting that the central cardiovascular system may be a target organ for these hormones (29, 30, 31, 32) .
A fal I In systemic vascular resistance appears to be common to most, If not al 1, Instances where cardiac enlargement occurs (pregnancy, estrogen administration, A-V fistula). To test the hypothesis that systemic vascular resistance has a primary role In determining left ventricular chamber size, hydralazlne (an arterial dilator) was administered chronlcal ly to guinea pigs.
METHODS

Choice Qf Experimental Animal
Male guinea pigs were chosen as the experimental model tor this study. Substantial I lterature exists using guinea pigs as models tor cardiovascular physiologic Investigation (3, 13, 33, 34, 35, 36, 37) .
Males were used to avoid any estrus related hormone varlabll lty. The guinea pig Is relatively smal I and easy to handle, but large enough tor thorough hemodynamlc Investigation. In addition, the Heart Research Laboratory has had extensive experience with this animal (13, 38, 39) . The above reasons made the guinea pig an attractive model tor the study of maternal cardiovascular physiology.
Choice Qf Pharmacologlc Dr:..ug
Hydralazlne was chosen as the drug to reduce vascular resistance primarily because of Its mechanism of action: relaxation of arterial smooth muscle, particularly at the arterioles (40) . It has no direct effects on the autonomic nervous system (40) 
Instrumentation
On the appropriate day, animals were given an Intramuscular 
• • ! • ,, Chronic Dosing .s.:t.u..d¥.
Fifteen animals were randomized to each study group. Table II shows body and left ventricular weights, total plasma volume, and hematocrlts. Al I animals gained weight during the study as would be expected of healthy, growing animals. Study groups were wel I matched as seen by similar mean body weights. Cardiac output was normal !zed to body weight so that different sized animals could be more accurately compared. Cardiac "Index"
(cardiac output/body weight) was sl lghtly higher In the treated group and systemic vascular resistance lower, but the differences were not slgnlf lcant. Stroke volumes were the same for both groups.
Plasma volume was slightly elevated In the treated group but not statlstlcal ly different. Hematocrlt was the same for both groups.
Left ventrlcular weights were the same for both groups. Left ventrlcular size at any given pressure was sllghtly larger for the treated group (Figure 7) , but again, not significant. animals. Although no changes I lsted above were statistically significant, the direction of the changes Is similar to that seen In pregnancy or sex steroid administration (12, 13) .
Hydralazlne was administered orally. The decision to use hydralazlne was based on several criteria: 1) hydralazlne Is easy to administer when dissolved In water; 2) hydralazlne Is easily absorbed;
3) hydralazlne has a bloavallabll lty of 30-50% which can be Increased If given simultaneously with sol Id food; 4) the area of action appears to be only on smooth muscle with no direct cardiac effects or effects on regulatory systems (40) . Other potential vasodllators Include captoprfl, prazosfn, phentolamlne, and nltroprusslde. These drugs were not used because of their potential effects on cardiac muscle directly, on complex Interaction with renal function, and/or the autonomic nervous system. Additionally, side effects associated with these drugs may have compl Jcated the Investigation.
Subacute hemodynamlc measurements were used for this study rather than chronic measurements. This helped to Insure that animals were tree from Infection at the time of study and also Insured a high percentage of catheter patency. Furthermore, this laboratory has demonstrated that subacute hemodynamlcs fol low Ing ketamlne/xylazlne anesthesia accurately reflects chronic hemodynamlcs In the guinea pig (44) .
In vitro passive pressure volume curves were used to evaluate left ventricular chamber size. It has been recognized that the In Hydralazlne was used to Increase the diameter of the resistance vessels (49, 50, 51) . A larger vessel provides less resistance and permits more flow: In mean arterial pressure. During prel lmlnary dosing studies It was possible to monitor blood pressure for up to two weeks. The fact that blood pressure was generally decreased Indicated that systemic vascular resistance was probably being decreased also (there was no reason to expect that cardiac output would have decreased). 
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Many of these mechanisms may have contributed to compensation against the effects of hydralazlne In this study. Short term mechanisms In general, however, lose their abll lty to control blood pressure after a few hours to a few days. This Is because the nervous pressure receptors lose their responsiveness and adapt. During the dose study the treated animals had lower blood pressures for up to two weeks. This would seem to Indicate that the hydralazlne given was effective enough to decrease blood pressure In spite of short term compensatory mechanisms.
A drop In arterial pressure greatly decreases the rate at which the kidneys excrete water and salt. This Is the result of the renalbody f luld mechanlsm. Thls long term mechanism Is complex and not completely understood. Briefly, It controls blood pressure primarily via blood volume. A decrease In pressure causes the kidneys to decrease the output of water and salt. In addition to this pressure (diuresis and natrluresls), the low pressure causes Increased secretion of renln by the kidneys, Increased aldosterone secretion by the adrenal cortices, and Increased sympathetic signals to the kidneys.
Al I these In turn decrease the renal output of water and salt by various submechanlsms.
In this study plasma volume was only Increased by 2 ml and was not statistically slgnlf lcant In the treated animals. However, It has been shown that a two percent increase In blood volume can Increase the mean circulatory fll ling pressure by five percent (52) . An Increase Jn cardiac output of f lve percent can Increase systemic vascular resistance 25-50%. These figures suggest that a two percent Increase In blood volume may Increase arterial pressure 30-57%. A smal I Increase Jn blood volume may therefore have been enough to cause blood pressure to stay near normal Jn the hydralazlne treated animals.
Of the many mechanisms that work to regulate blood pressure directly and systemic vascular resistance Indirectly, only one was the focus of this study: that of local vasomotlon. It ls possible that compensatory mechanisms such as the renal fluid-body and renlnanglotensln mechanisms were engaged to such a degree that treated animal hemodynamics remained In normal ranges. One way to further address this problem would be to manipulate more than one hemodynamlc control mechanism at a time. For example, a future study could vasodllate locally as In this study and at the same time Inhibit anglotensln with a drug such as captoprll. Then a portion of both the long and short term control systems would be affected.
This study was unable to provide conclusive evidence that systemic vascular resistance ls a signal for heart size. The primary dlfflcultles experienced seemed to stem from an lnabll ity to maintain a decreased systemic vascular resistance. The hypothesized results appeared Jn the form of trends al I Jn the expected directions (increased cardiac output, left ventricular chamber size, and stroke volume), but were not statistically significant. In order to study the effects of systemic vascular resistance on heart size, future studies may have to direct efforts of control ling more than one hemodynamlc control mechanism. This could be accompl I shed with multiple drugs administered simultaneously.
